近日，北京同仁堂集团发布通报，责令旗下子公司同仁堂科技前高管李声义辞职。此举源于此前媒体曝光的‘过期蜂蜜事件’后续追责行动。2018年，同仁堂被曝出其子公司回收并使用过期蜂蜜作为原料，引发公众对中药老字号产品质量安全的广泛关注。事件发生后，监管部门介入调查，多名相关责任人被问责。此次责令李声义辞职，是企业深化内部整改、强化合规管理的重要举措，也体现了同仁堂重塑品牌形象、重建消费者信任的决心。作为拥有350多年历史的中华老字号，同仁堂一直以‘炮制虽繁必不敢省人工，品味虽贵必不敢减物力’为宗旨。此次人事调整不仅是一次个案处理，更是对整个中医药行业质量管理与企业治理提出更高要求的信号。未来，同仁堂需在传承传统工艺的同时，进一步完善现代企业制度，确保产品质量与品牌声誉双提升。
Recently, Beijing Tongrentang Group announced that it has ordered Li Shengyi, a former senior executive of its subsidiary Tongrentang Tech, to resign. This decision stems from ongoing accountability measures following the widely reported ‘expired honey incident.’ In 2018, Tongrentang was exposed for recycling and using expired honey as raw material in its products, sparking widespread public concern over product safety at this centuries-old Chinese herbal medicine brand. After the incident, regulatory authorities launched investigations, leading to disciplinary actions against multiple responsible individuals. The current directive for Li’s resignation reflects the company’s commitment to internal reform and enhanced compliance management, underscoring Tongrentang’s determination to restore its brand image and rebuild consumer trust. With a heritage spanning over 350 years, Tongrentang has long upheld the principle: ‘No matter how complicated the preparation, we never skimp on effort; no matter how expensive the ingredients, we never reduce quality.’ This personnel change is not merely an isolated disciplinary action—it also signals a broader call for stricter quality control and corporate governance across the entire traditional Chinese medicine industry. Moving forward, Tongrentang must balance its rich heritage with modern corporate practices to ensure both product integrity and brand reputation.
原创文章，作者：admin，如若转载，请注明出处：https://ktez.cn/5075.html